[1]Beyer C,Zampetaki A,Lin NY,et al.Signature of circulating microRNAs in osteoarthritis.[J].Ann Rheum Dis,2015,74(3):e18.
[2]Pereira D,Ramos E,Branco J.Osteoarthritis[J].Acta Med Port,2015,28(1):99-106.
[3]Lane NE,Shidara K,Wise BL.Osteoarthritis year in review 2016:clinical[J].Osteoarthritis Cartilage,2017,25(2):209-215.
[4]Lee WJ,Hase K.Gut microbiota-generated metabolites in animal health and disease[J].Nat Chem Biol,2014,10(6):416-424.
[5]Yoo JY,Kim SS.Probiotics and prebiotics:present status and future perspectives on metabolic disorders[J].Nutrients,2016,8(3):173.
[6]Biedermann L,Rogler G.The intestinal microbiota:its role in health and disease[J].Eur J Pediatr,2015,174(2):151-167.
[7]Kasubuchi M,Hasegawa S,Hiramatsu T,et al.Dietary gut microbial metabolites,short-chain fatty acids,and host metabolic regulation[J].Nutrients,2015,7(4):2839-2849.
[8]Lee WJ,Brey PT.How microbiomes influence metazoan development:insights from history and Drosophila modeling of gut-microbe interactions[J].Annu Rev Cell Dev Biol,2013,29(6):571-592.
[9]Bottacini F,van Sinderen D,Ventura M.Omics of bifidobacteria:research and insights into their health-promoting activities[J].Biochem J,2017,74(24):4137-4152.
[10]Walker A,Pfitzner B,Neschen S,et al.Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet[J].Isme J,2014,8(12):2380-2396.
[11]Yang L,Bian G,Zhu W.Interactions between the monogastric animal gut microbiota and the intestinal immune function-a review[J].WeiShengWu XueBao,2014,54(5):480-486.
[12]Macpherson AJ,Mccoy KD.Standardised animal models of host microbial mutualism[J].Mucosal Immunology,2014,8(3):476.
[13]Cao AT,Yao S,Gong B,et al.Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis[J].J Immunol,2012,189(9):4666-4673.
[14]阳乐,许鹏.促炎细胞因子与骨关节炎[J].中华骨与关节外科杂志,2015,8(5):455-459.
[15]Catana CS,Berindan Neagoe I,Cozma V,et al.Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease[J].World J Gastroenterol,2015,21(19):5823-5830.
[16]Keyel PA.How is inflammation initiated? Individual influences of IL-1,IL-18 and HMGB1[J].Cytokine,2014,69(1):136-145.
[17]Frosali S,Pagliari D,Gambassi G,et al.How the intricate interaction among toll-Like receptors,microbiota,and intestinal immunity can influence gastrointestinal pathology[J/OL].J Immunol Res,2015,2015:489821.[2015-06-20].hppt://10.1155/2015/489821.
[18]Haseeb A,Haqqi TM.Immunopathogenesis of osteoarthritis[J].Clin Immunol,2013,146(3):185-196.
[19]Abella V,Scotece M,Conde J,et al.The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1[J].Sci Rep,2016,6(1):20356.
[20]Sillat T,Barreto G,Clarijs P,et al.Tolllike receptors in human chondrocytes and osteoarthritic cartilage[J].Acta Orthop,2013,84(6):585-592.
[21]Gomez R,Villalvilla A,Largo R,et al.TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs[J].Nat Rev Rheumatol,2015,11(3):159-170.
[22]Barreto G,Sandelin J,Salem A,et al.Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints[J].Acta Orthop,2017,88(3):326-333.
[23]Silawal S,Triebel J,Bertsch T,et al.Osteoarthritis and the complement cascade[J].Clin Med Insights Arthritis Musculoskelet Disord,2018,3(11):1179544117751430.
[24]Holers VM,Banda NK.Complement in the initiation and evolution of rheumatoid arthritis[J].Front Immunol,2018,28(9):1057.
[25]Lepus CM,Song JJ,Wang Q,et al.Brief report:carboxypeptidase B serves as a protective mediator in osteoarthritis[J].Arthritis Rheumatol,2014,66(1):101-106.
[26]Portune KJ,BenitezPaez A,Del Pulgar EM,et al.Gut microbiota,diet,and obesity-related disorders-The good,the bad,and the future challenges[J].Mol Nutr Food Res,2017,61(1):1600252.
[27]Hamada D,Maynard R,Schott E,et al.Suppressive effects of insulin on tumor necrosis factor-dependent early osteoarthritic changes associated with obesity and type 2 diabetes mellitus[J].Arthritis Rheumatol,2016,68(6):1392-1402.
[28]刘洋,李可峰,董贵俊,等.肠道菌群在运动改善肥胖性骨关节炎中的作用[J].体育科学,2018,38(4):85-91;97.
[29]Huang Z,Kraus VB.Does lipopolysaccharide-mediated inflammation have a role in OA?[J].Nature Reviews Rheumatology,2015,12(2):123.
[30]Huang ZY,Stabler T,Pei FX,et al.Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation[J].Osteoarthritis Cartilage,2016,24(10):1769-1775.
[31]Cani PD,Bibiloni R,Knauf C,et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J].Diabetes,2008,57(6):1470-1481.
[32]Collins KH,Paul HA,Reimer RA,et al.Relationship between inflammation,the gut microbiota,and metabolic osteoarthritis development:studies in a rat model[J].Osteoarthritis Cartilage,2015,23(11):1989-1998.
[33]O'Toole PW,Jeffery IB.Gut microbiota and aging[J].Science,2015,350(6265):1214-1215.
[34]Clark RI,Salazar A,Yamada R,et al.Distinct shifts in microbiota composition during drosophila aging impair intestinal function and drive mortality[J].Cell Rep,2015,12(10):1656-1667.
[35]Li H,Qi Y,Jasper H.Preventing age-related decline of gut compartmentalization limits microbiota dysbiosis and extends lifespan[J].Cell Host Microbe,2016,19(2):240-253.
[36]Li Y,Luo W,Deng Z,et al.Diet-Intestinal microbiota axis in osteoarthritis:A possiblerole[J/OL].Mediators Inflamm,2016,2016:3495173.[2016-09-10].http://10.1155/2016/3495173.
[37]Ghoshal UC,Gwee KA,Holtmann G,et al.The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region[J].J Gastroenterol Hepatol,2018,33(1):57-59.
[38]Wang H,Ni X,Qing X,et al.Probiotic lactobacillus johnsonii BS15 improves blood parameters related to immunity in broilers experimentally infected with subclinical necrotic enteritis[J].Front Microbiol,2018(9):49.
[39]Belkaid Y,Hand T.Role of the microbiota in immunity and inflammation[J].Cell,2014,157(1):121-141.
[40]Schott EM,Farnsworth CW,Grier A,et al.Targeting the gut microbiome to treat the osteoarthritis of obesity[J].JCI Insight,2018,3(8):e95997.
[41]Vogt L,Meyer D,Pullens G,et al.Immunological properties of inulin-type fructans[J].Crit Rev Food Sci Nutr,2015,55(3):414-436.
[42]Wu RY,Maattanen P,Napper S,et al.Non-digestible oligosaccharides directly regulate host kinome to modulate host inflammatory responses without alterations in the gut microbiota[J].Microbiome,2017,5(1):135.
[43]Kashyap PC,Quigley EM.Therapeutic implications of the gastrointestinal microbiome[J].Curr Opin Pharmacol,2018(38):90-96.